RecruitingPhase 3NCT07404865
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Sponsor: Vor Biopharma
Boise, ID · +46 more sites
1 recruiting rheumatoid arthritis studies with a site in Boise, ID.
Sponsor: Vor Biopharma
Boise, ID · +46 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.